chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a certified medical assistant refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. On 22-SEP-2014, the patient was inadvertently vaccinated with RECOMBIVAX HB, injection, (lot # J014312; Exp. date: 07-SEP-2014) (route of administration was not provided). Co-suspect or concomitant therapies were not reported. The dose administered had expired. No adverse effects reported. Additional information has been requested.
pt recvd vax & devel fever 103 & rash, joint swelling, reddness & pain; seen by MD feels it was vax react; had CBC area weekend that was WNL;
Aching arm and shoulder and back by 7:00 pm the same evening. Cold. Tired. Took one ADVIL. Slept eight hours, woke Stayed a wake for an hour and then slept four hours.
Consistently, Weak/exhausted/no appetite/constipated since 1 hour from shot on 4/27. Fever/Headache coming and going mostly in the 5 days following shot, better in the last few days. Headaches severe 3-4 days after shot.
Arm soreness; Drowsiness; Overall muscle ache; This is a spontaneous report from a contactable consumer. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via intramuscular route of administration in the left arm on 23Apr2021 at 10:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via intramuscular route of administration in the left arm on 01Apr2021 at 11:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 19:00, the patient experienced arm soreness, drowsiness and overall muscle ache. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm soreness, drowsiness and overall muscle ache was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
tested positive following the first dose of vaccine; tested positive following the first dose of vaccine; This is a spontaneous report from a contactable healthcare professional. A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that she has a patient who tested positive following the first dose of vaccine and inquiring as to second dose recommendations. The outcome of the event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: There is scant information at this point. Case will be reevaluated based on additional information during the follow-up
Patient said she started feeling sore in her upper arm about 48 hours after receiving the vaccination.
GUILLAIN BARRE Syndrome - I received Tdap 7/23/10. Symptoms began 8/4/10 with bilateral paresthesias. Symptoms progressed over next five days to ascending paresthesias, weakness, difficulty walking, headache nausea. Admitted 8/8/10 by ER - noticed to have absent reflexes. Hospitalized 8/8/10 --> 8/11/10.
The client presented at HD on 9/5/13 with localized swelling on her right posterior upper arm measuring 4" in diameter with a 2" darker red inner circle. The area was warm to the touch and tender.  The onset of the swelling was 9/4/13 in the am and per the client it may be improved 24 hrs. after the onset. She was counseled about the symptoms of cellulitis and advised to use comfort measures such as ice, Motrin, or Tylenol. She was advised to seek medical care if the redness increased, she became febrile, or if increasing discomfort ensued.  The Tdap injection site over the right deltoid was only slightly tender, and not reddened.
Patient reports left arm is still sore after 2 months of receiving vaccination. Also reports decreased mobility in left shoulder.
Infant had vaccines on Tuesday 23rd and child was put to bed healthy on Fri 26th; parents checked on him at 1:30 AM Sat 27th and child was dead. Dx-Sudden Infant Death Syndrome.
I got my booster at a Pharmacy in the evening  of November24, 2021. The next morning  I felt my heart fluttering and slight pressure in my chest that would come and go. I felt shaky, very tired and had a headache. As the day went on I continued to have a headache, fatigue, and heart flutters and heaviness in my chest that would come and go.  I went to my doctor on December 3, 2021 for a physical and she did a EKG which was normal.  My heart flutters happen when I'm at rest as well as when  I'm walking around. Today is the 14th day after my COVID booster and the headache is gone and the brain fog, fatigue and shakiness is getting better but I'm still having the heart flutters. As soon as I woke up today and opened my eyes today I had a big flutter and as I write this I am having smaller flutters.
This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Covid vaccine administered 10 days early) and NO ADVERSE EVENT (No adverse event) in a 33-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 015B22A and 015B22A) for COVID-19 prophylaxis.     Patient had no known drug allergies. Patient had no acute illness at the time of vaccination and up to one month before.  Patient had not received other vaccines within one month prior to any dose of Moderna COVID-19 vaccine.  Concurrent medical conditions included Asthma (No recent changes in conditions status.). Concomitant products included LORATADINE (CLARITIN [LORATADINE]), MONTELUKAST SODIUM (SINGULAIR) and ALBUTEROL SULFATE for an unknown indication.   On 19-Dec-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 06-Jan-2023, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to .5 milliliter. On 06-Jan-2023, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Covid vaccine administered 10 days early). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Covid vaccine administered 10 days early) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Covid vaccine administered 10 days early).    No other vaccine given on the same day as Moderna COVID-19 vaccine.  It was reported that, the patient had received 2nd COVID vaccine 10 days too early.  No adverse event reported.  No treatment medications were reported.
Patient given MMR, VARIVAX, Hep A vaccines on 3/18/2011. Patient subsequently developed salmonella gastroenteritis followed by a morbilliform rash. Was on Amoxil 3/18/11 for OM as well. Hospitalized due to rash and concerns for Stevens Johnson syndrome-never developed.
Information has been received from a medical assistant referring to an unspecified patient. Information regarding medical history, concurrent condition or concomitant medication was not provided. The reporter stated on an unknown date the patient might receive an improperly stored dose of one of the following vaccines, but she was not sure which of the lots of the patient received. The vaccines were stored in the range of 47 Fahrenheit to 77 Fahrenheit for 35 minutes and they were previously stored in 47 Fahrenheit to 77 Fahrenheit for 56 minutes. No adverse effects reported. Names of vaccines involved, VAQTA (lot# N005274, expiration date 03-APR-2018, dose unspecified, data logger); GARDASIL 9 (lot# M041990, expiration date 28-JUN-2019 or lot# M040412, expiration date 30-JUN-2019; dose unspecified, data logger); ROTATEQ (lot # M042169, 08-JUN-2018 or lot# M042169, expiration date 22-JUN-2018; dose unspecified, data logger); LIQUID PEDVAXHIB (lot# N003698, expiration date 31-OCT-2019 or lot# N003701, expiration date 01-NOV-2019; dose unspecified, data logger); RECOMBIVAX HB (lot# M045654, expiration date 03-JUL-2019, dose unspecified, data logger) for prophylaxis.
fever to 103, myalgia, negative flu and strep improving 9 days later.
Onset of co-infection of CMV that has left me with ?chronic fatigue syndrome? debilitating fatigue, malaise, burning, numbness, twitches, muscle loss and weakness, weight loss, insomnia, vertigo/vestibular issues, chronic pain, inability to focus, had to resign from job.. previously healthy young woman
This case was reported by a healthcare professional and described the occurrence of anemia in a female subject of unspecified age who was vaccinated with ENGERIX B, GlaxoSmithKline. Previous and/or concurrent vaccination included TDAP, non-gsk; unk; unknown given on 24 October 2008; live attenuated MMR (strain not specified); manufacturer unspecified; unknown given on 24 October 2008; MMR, strain not specified; manufacturer unspecified; unknown given on 24 October 2008. On 24 October 2008, the subject received 1st dose of ENGERIX B (unknown, left arm). Three to four days after vaccination with ENGERIX B, the subject experienced rash. On 01 December 2008, 38 days after vaccination with ENGERIX B, the subject experienced anemia and psoriasis. The healthcare professional was reporting on behalf of a clinic nurse. A female subject received ENGERIX B on 24 October 2008; and three to four day later developed a rash on her chest, back and torso. On 01 December 2008, the subject was seen at a dermatologist's office and diagnosed with psoriasis and anemia. Immunization series was discontinued. The reporter stated there was a 10-degree temperature excursion on this lot number and implemented a voluntary recall (incorrect storage of drug). This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events were unspecified.
Fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (Tired) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 28-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and FATIGUE (Tired). At the time of the report, PYREXIA (Fever) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
She passed out and had a seizure for about 15 seconds with urinary incontinence. She vomited 2-3 times when she regained consciousness.
Arm became itchy and had hives. Mom gave Benadryl. Hives did not return. Vaccines were given in the same arm so unsure of which vaccine the reaction was from.
W/in 10 minutes of inject felt weak, lightheaded, dizzy, had heart palpitations, tachycardia, diaphoresis, chest tightness, inc respirations & felt waves of strange sensation; rx: med in ER; to watch for signs of further allergic problems;
Pt. called pharmacy and reported decreased right arm mobility and pain approximately 1-2 hours after receiving vaccine. Patient was advised to self-treat w/ibuprofen and BENADRYL, and to call back if pain persists. On 10/21/2010 am patient was called at home and reported improved pain & mobility.
Ringing developed in my left ear about ten days later and has not subsided. It will occasionally stop ringing for several hours but it always comes back. The ringing eventually spread from my left ear to both ears and is very loud/distracting
fussy, crying  2-3hr, swelling @ site of inj tx w/APAP, compresses
I discovered  pain and swelling in left leg, noticeably upon retiring.  Called Dr. Family Medicine. Dr. scheduled image with Center For Imaging. Visit with Doctor, 05- 07- 21, visit with Imaging on 05- 07- 21. Diagnosis same night,  Eliquis prescribed 05-07- 21. Visit with Dr. ( previously scheduled). 06-09-21. I wanted to inform CDC in case studies are on going.
pt died 2 days following administration of vax; Reporter stated "doubt that was related; Autopsy results pending;
Patient describes symptoms of chills, sweats, fever and body aches for 36 hours following  the vaccination. Pt took Advil OTC which alleviated symptoms. Pt is doing fine now.
BROKE OUT IN HIVES; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced broke out in hives. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of broke out in hives was not reported. This report was non-serious.
Chest heaviness/pain accompanied by fatigue, dizziness, shortness of breath, and nausea.  Given the combination of symptoms, I presented to a local emergency room to be evaluated for a heart condition.  ER doctor evaluated to rule out heart attack, stroke, and/or blot clot.  All tests appeared normal.  Symptoms attributed to side effects from vaccination.
Entire right arm was wollen red and warm. Spread to breasts, should blades, and down to elbow. Sore to the touch. No anaphylactic reactions. Just swelling. By 12/5/22, swelling was still present but better.
Three days after vaccine was administered, client c/o nausea & diarrhea, headache. Ten days after vaccine administered, client has broken out in hives over her torso. Says it is vey itchy.
Faulty needle, administered less than 0.3 mL of dosage. Patient was readministered with a full dose of 0.3 mL in the right deltoid afterwards.
Pt seen in primary care clinic on 7-25-12 with neck pain and lumps that started about 2 week after smallpox vaccination. Per provider the vaccination area was covered with bandaid and site was scabbed over.  Entire region had induration and erythema. Pt given Toradol 60 mg injection in clinic and advised to do warm compresses. Pt seen in ER on 7-1-12 with rash and headache. Given Decadron 10 mg orally in ER and discharged with rx's for Benadryl and Fioricet. Pt seen in primary care clinic on 7-27 after being referred back from ER with complaints of itchy, small blisters on extremities, trunk and face. PCP suspected possible self innoculation, gave rx's for Benadryl and Atarax, and referred patient to dermatology clinic. Dermatologist's exam noted 20 papules approximately 0.5-1 cm with central crust formaulation and halo of erythema. Punch biopsy was done of a representative lesion. Pt was started on Cotrimoxazole DS, Bactroban to nares, and Hibiclens wash to cover for possible MRSA and advised to continue the Atarax for nighttime itching. Biopsy noted that there was bacterial colonization of the lesion; fungal stains were negative, gram stains highlights gram positive cocci. Differential diagnosis included post-smallpox vaccine papular spongiotic dermatitis with mechanical trauma, erythema multiforme, and eczema vaccinatum.
arm hurt a little bit after the shot; low white blood cell count; medical history included multiple myeloma for 5 years and compromised immune system; medical history included multiple myeloma for 5 years and compromised immune system; This is a spontaneous report from a contactable consumer reported for self. This male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) via unspecified route of administration on 14Jan2021 at single dose in arm for COVID-19 immunization. The patient's medical history included multiple myeloma for 5 years and compromised immune system (at least he assumed he did). The patient's concomitant medications were not reported. The patient previously received lenalidomide (REVLIMID) 5mg for about 15 days during a month for multiple myeloma. The patient had no other side effects to the vaccine other than arm hurt a little bit after the shot, which he stated was good in his book because it may indicate that had reaction to the vaccine. The patient stated that he had had a compromised immune system, and had a low white blood cell count on an unspecified date. The patient asked for information if he should stop lenalidomide and information with regards to using ibuprofen, paracetamol (TYLENOL), or acetylsalicylic acid (ASPIRIN) after the vaccine. The patient asked about alcohol, any dos and don'ts after the vaccination. The patient also asked how proved that the vaccine worked in old people and if any difference between the results in young and old people. The outcome of events was unknown. The patient is due for the second dose on 04Feb2021.  Information about lot/batch number has been requested.
Soreness (:) deltoid 8/22, then 8/24 developed redness, warmth and swelling. Redness and swelling decreased 8/25. Light headed briefly at school 8/25 - resolved. Tried BENADRYL at hs.
Chills; Slight temperature; Soreness atinjection site; This is a spontaneous report from a contactable patient. A 59-year-old non-pregnant female patient received second dose of BNT162B2 (BNT162B2, lot number: EL3247), via unknown route of administration in left arm on 16Mar2021 at 9.30 hours (at the age of 59 years of vaccination) as a single dose for Covid-19 immunisation. Medical history included high blood pressure. The patient did not have any allergies to medications, food or other products. Concomitant medication included olmesartan medoxomil 20 mg (MANUFACTURER UNKNOWN) for an unknown indication and its unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccine within 4 weeks of vaccination. On 17Mar2021 at 16.00 hours, the patient experienced chills, slight temperature and soreness at injection site. Patient received treatment with two Tylenol for the events. The clinical outcome for the events chills, slight temperature and soreness at injection site was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Started feeling poorly early in the week. I was supposed to going to visit my grandkids but thought maybe I should check and make sure we did not have CoVID. I had not tested yet but on Monday the 9th. I had a high fever so I ended up testing and was positive. I have been super weak and tired. Had sinus issues and a ton of congestion but I do not think I have much of a fever since the first time that made me test.
Tingling down both sides of his neck lasting approximately 10 minutes, starting 10 minutes after administration.
5NOV96 630PM pt devel a sore throat, puffy eyes, racing heart beat, throat began to swell shut & itching;pt went to ER where recv adrenalin & began to feel better pt was sent home w/med;
6cm area of erythema with modest induration approx 5cm distal to injection site 24 hrs post injection. C/O weakness, numbness and tingling in left hand 36 hrs post injection with severe pain at radial and ? pulses intact capillary refill wnl treated with Keflex (antibiotic) and Medrol dose pak (steroid). 2/26/03 weakness improved. Local reaction resolved. Still has numbness and tingling.
Patient presents with reddish, cluster of bumps on back of arm.  She states that she did not notice it until it itched that day and she looked and saw "little pimples that were red-like".  She thought she had been bit by something but then she remember that a month or so ago that is where she received her Zostavax vaccination. She does not know how long it might have actually been there, since she can't see that area.
congestion/COPD has a flair; This is a spontaneous report from a contactable consumer. A 85-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection and Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. The historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection and Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the 2nd shot of Pfizer vaccine. On an unspecified date, the patient experienced congestion/COPD has a flair for every couple of events. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pregnancy; Left arm soreness; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) and PAIN IN EXTREMITY (Left arm soreness) in a 35-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Abortion (The patient had a spontaneous abortion.) on 01-Aug-2017 and Pregnancy (The patient had a live full term birth.) on 23-Jun-2018. Previously administered products included for an unreported indication: ALCOHOL until 01-Nov-2020. Concurrent medical conditions included No adverse event and No adverse event. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 04-Aug-2020 and the estimated date of delivery was 11-May-2021. On 04-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) and PAIN IN EXTREMITY (Left arm soreness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. On 07-Mar-2021, PAIN IN EXTREMITY (Left arm soreness) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Sep-2020, Pregnancy test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Live, Full term birth was reported on 23-Jun-2018.
Vaccine administered Friday afternoon, July 17, by physician.  Saturday afternoon had uncomfortable skin soreness on left shoulder.  Examined to find scattered red welts leading down to armpit.  From then to late Monday, welts gradually abated.